These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2703 related items for PubMed ID: 29929635

  • 1. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C, Blazek S, Rommel KP, Noack T, von Roeder M, Luecke C, Seeburger J, Ender J, Borger MA, Linke A, Gutberlet M, Thiele H, Lurz P.
    JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1142-1151. PubMed ID: 29929635
    [Abstract] [Full Text] [Related]

  • 2. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M, Karam N, Taramasso M, Ouarrak T, Schneider S, Lurz P, von Bardeleben RS, Fam N, Pozzoli A, Lubos E, Boekstegers P, Schillinger W, Plicht B, Eggebrecht H, Baldus S, Senges J, Maisano F, Hausleiter J, TriValve and TRAMI Investigators.
    JACC Cardiovasc Interv; 2020 Mar 09; 13(5):543-550. PubMed ID: 31954679
    [Abstract] [Full Text] [Related]

  • 3. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
    Besler C, Orban M, Rommel KP, Braun D, Patel M, Hagl C, Borger M, Nabauer M, Massberg S, Thiele H, Hausleiter J, Lurz P.
    JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1119-1128. PubMed ID: 29929631
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.
    Gyoten T, Messroghli D, Schenk S, Rochor K, Grimmig O, Just S, Fritzsche D.
    Open Heart; 2020 Jun 25; 7(1):e001203. PubMed ID: 32201589
    [Abstract] [Full Text] [Related]

  • 6. Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.
    Mahowald MK, Pislaru SV, Reeder GS, Padang R, Michelena HI, Mankad SV, Maalouf JF, Guerrero M, Alkhouli M, Rihal CS, Eleid MF.
    Catheter Cardiovasc Interv; 2020 Nov 25; 96(6):1323-1330. PubMed ID: 32180349
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physiological and Clinical Consequences of Right Ventricular Volume Overload Reduction After Transcatheter Treatment for Tricuspid Regurgitation.
    Rommel KP, Besler C, Noack T, Blazek S, von Roeder M, Fengler K, Ender J, Gutberlet M, Desch S, Borger MA, Thiele H, Lurz P.
    JACC Cardiovasc Interv; 2019 Aug 12; 12(15):1423-1434. PubMed ID: 31326430
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.
    Asmarats L, Perlman G, Praz F, Hensey M, Chrissoheris MP, Philippon F, Ofek H, Ye J, Puri R, Pibarot P, Attinger A, Moss R, Bédard E, Moschovitis A, Reineke D, Lauck S, Blanke P, Leipsic J, Spargias K, Windecker S, Webb JG, Rodés-Cabau J.
    JACC Cardiovasc Interv; 2019 Aug 12; 12(15):1438-1447. PubMed ID: 31395213
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Louriero R, Fam N, Frerker C, Ho E, Juliard JM, Kaple R, Kodali S, Kreidel F, Kuck KH, Lauten A, Lurz J, Monivas V, Mehr M, Nazif T, Nickening G, Pedrazzini G, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Tang GHL, Khattab AA, Thiele H, Unterhuber M, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Hausleiter J, Lurz P, Maisano F, Leon MB, Hahn RT.
    JACC Cardiovasc Interv; 2020 Mar 09; 13(5):554-564. PubMed ID: 31954676
    [Abstract] [Full Text] [Related]

  • 14. 2-Year Outcomes After Transcatheter Mitral Valve Replacement.
    Regueiro A, Ye J, Fam N, Bapat VN, Dagenais F, Peterson MD, Windecker S, Webb JG, Rodés-Cabau J.
    JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1671-1678. PubMed ID: 28838478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of Baseline Tricuspid Regurgitation With Health Status and Clinical Outcomes After TAVR and Mitral TEER.
    Sammour YM, Cohen DJ, Arnold S, Spertus JA, Stebbins A, Vekstein A, Kosinski AS, Goel SS, Kleiman NS, Vemulapalli S, Kapadia SR.
    JACC Cardiovasc Interv; 2024 Aug 26; 17(16):1905-1915. PubMed ID: 39197989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement.
    Hasan SA, Morsi M, Frakes BS, Bryson ME, Schmidt CW, Seshiah P, Choo J, Smith JM, Answini GA, Stewart-Dehner TL, Yasar SJ, Jollis JG, Berlacher MD, Ratajczak TM, Chung ES, Kereiakes DJ, Garcia S.
    Cardiovasc Revasc Med; 2024 Jul 26; 64():1-4. PubMed ID: 38355340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring.
    Lloyd JW, Joseph TA, Cabalka AK, Guerrero M, Rihal CS, Eleid MF.
    Catheter Cardiovasc Interv; 2019 Sep 01; 94(3):458-466. PubMed ID: 30790436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 136.